In 1988, amphiregulin (AR), an epidermal growth factor (EGF)-like growth factor, was found to bind only to the EGF receptor (EGFR) and regulate the growth of MCF-7 breast tumor cells in a serum-free medium (1). Here, EGF is linked to breast neoplasm.